Columbus, OH, United States of America

Flavia Pichiorri

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Flavia Pichiorri: Innovator in Multiple Myeloma Treatment

Introduction

Flavia Pichiorri is a prominent inventor based in Columbus, OH (US). She has made significant contributions to the field of cancer treatment, particularly in the area of multiple myeloma. Her innovative work has led to the development of methods and compositions that enhance the effectiveness of existing treatments.

Latest Patents

Flavia holds 1 patent for her invention titled "Methods and compositions for treating multiple myeloma." This patent provides methods for sensitizing multiple myeloma cells to treatment with immunomodulatory drugs (IMiDs). The aspects of her invention include the administration of AR-42 alongside IMiDs, such as lenalidomide and pomalidomide, to improve treatment outcomes for multiple myeloma patients.

Career Highlights

Flavia Pichiorri is associated with the Ohio State Innovation Foundation, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving therapeutic strategies for cancer patients, showcasing her dedication to the field of oncology.

Collaborations

Flavia collaborates with Craig Hofmeister, a fellow researcher in the field. Their partnership exemplifies the collaborative spirit of scientific research, as they work together to enhance treatment options for patients suffering from multiple myeloma.

Conclusion

Flavia Pichiorri's contributions to the treatment of multiple myeloma highlight her role as an innovative inventor in the medical field. Her patent and ongoing research efforts reflect her commitment to improving patient care and advancing cancer treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…